Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) traded down 1.5% during trading on Thursday . The stock traded as low as $8.58 and last traded at $8.62. 34,054 shares traded hands during mid-day trading, a decline of 35% from the average session volume of 52,536 shares. The stock had previously closed at $8.75.
Wall Street Analyst Weigh In
Separately, Citigroup upgraded shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a report on Friday, October 25th.
View Our Latest Report on FSNUY
Fresenius SE & Co. KGaA Stock Performance
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Featured Stories
- Five stocks we like better than Fresenius SE & Co. KGaA
- Health Care Stocks Explained: Why You Might Want to Invest
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Nebius Group: The Rising Star in AI Infrastructure
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.